U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Elevated circulating insulin:C-peptide ratio

MedGen UID:
1815107
Concept ID:
C5706201
Finding
HPO: HP:0034384

Definition

Increased ratio of insulin to C-peptide in the blood circulation. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVElevated circulating insulin:C-peptide ratio

Conditions with this feature

Hyperinsulinism due to INSR deficiency
MedGen UID:
355335
Concept ID:
C1864952
Disease or Syndrome
The severity of congenital hyperinsulinism varies widely among affected individuals, even among members of the same family. About 60 percent of infants with this condition experience a hypoglycemic episode within the first month of life. Other affected children develop hypoglycemia by early childhood. Unlike typical episodes of hypoglycemia, which occur most often after periods without food (fasting) or after exercising, episodes of hypoglycemia in people with congenital hyperinsulinism can also occur after eating.\n\nCongenital hyperinsulinism is a condition that causes individuals to have abnormally high levels of insulin. Insulin is a hormone that helps control levels of blood glucose, also called blood sugar. People with this condition have frequent episodes of low blood glucose (hypoglycemia). In infants and young children, these episodes are characterized by a lack of energy (lethargy), irritability, or difficulty feeding. Repeated episodes of low blood glucose increase the risk for serious complications such as breathing difficulties, seizures, intellectual disability, vision loss, brain damage, and coma.

Recent clinical studies

Etiology

Vidal AC, Lund PK, Hoyo C, Galanko J, Burcal L, Holston R, Massa B, Omofoye O, Sandler RS, Keku TO
BMC Cancer 2012 Sep 5;12:389. doi: 10.1186/1471-2407-12-389. PMID: 22950808Free PMC Article
Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG
J Acquir Immune Defic Syndr 1999 Jul 1;21(3):209-16. doi: 10.1097/00126334-199907010-00005. PMID: 10421244Free PMC Article

Therapy

Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG
J Acquir Immune Defic Syndr 1999 Jul 1;21(3):209-16. doi: 10.1097/00126334-199907010-00005. PMID: 10421244Free PMC Article

Prognosis

Vidal AC, Lund PK, Hoyo C, Galanko J, Burcal L, Holston R, Massa B, Omofoye O, Sandler RS, Keku TO
BMC Cancer 2012 Sep 5;12:389. doi: 10.1186/1471-2407-12-389. PMID: 22950808Free PMC Article

Clinical prediction guides

Vidal AC, Lund PK, Hoyo C, Galanko J, Burcal L, Holston R, Massa B, Omofoye O, Sandler RS, Keku TO
BMC Cancer 2012 Sep 5;12:389. doi: 10.1186/1471-2407-12-389. PMID: 22950808Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...